Xu‐Chao Zhang
- Pulmonary and Respiratory Medicine top 0.5%
- Oncology top 0.5%
- Molecular Biology top 5%
- Cancer Research top 1%
- Immunology top 10%
- Topics
- Lung Cancer Treatments and Mutations (121 papers)Lung Cancer Research Studies (36 papers)Cancer Genomics and Diagnostics (33 papers)
- Journals
- Nature CommunicationsJournal of Clinical OncologySHILAP Revista de lepidopterología
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Xu‐Chao Zhang
158 papers receiving 5.1k citations
Hit Papers
Peers
Comparison fields: 5 of 133
- Pulmonary and Respiratory Medicine 3.7k
- Oncology 3.3k
- Molecular Biology 1.6k
- Cancer Research 1.4k
- Immunology 385
Countries citing papers authored by Xu‐Chao Zhang
This map shows the geographic impact of Xu‐Chao Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xu‐Chao Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xu‐Chao Zhang more than expected).
Fields of papers citing papers by Xu‐Chao Zhang
This network shows the impact of papers produced by Xu‐Chao Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xu‐Chao Zhang. The network helps show where Xu‐Chao Zhang may publish in the future.
Co-authorship network of co-authors of Xu‐Chao Zhang
This figure shows the co-authorship network connecting the top 25 collaborators of Xu‐Chao Zhang. A scholar is included among the top collaborators of Xu‐Chao Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xu‐Chao Zhang. Xu‐Chao Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | The role of institutional quality in the nexus between green financing and sustainable developmentbreakdown → | 41 |
| 5 | 25 | |
| 6 | 11 | |
| 7 | 4 | |
| 8 | 18 | |
| 9 | 2 | |
| 10 | 11 | |
| 11 | 19 | |
| 12 | 9 | |
| 13 | 146 | |
| 14 | 35 | |
| 15 | 12 | |
| 16 | 17 | |
| 17 | 1 | |
| 18 | Potential Predictive Value of TP53 and KRAS Mutation Status for Response to PD-1 Blockade Immunotherapy in Lung Adenocarcinomabreakdown → | 741 |
| 19 | 135 | |
| 20 | 22 |
About Xu‐Chao Zhang
Xu‐Chao Zhang is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research, having authored 162 papers that have together received 5.2k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (121 papers), Lung Cancer Research Studies (36 papers) and Cancer Genomics and Diagnostics (33 papers). The work is most often cited by research in Oncology (3.3k citations), Pulmonary and Respiratory Medicine (3.7k citations) and Cancer Research (1.4k citations). Xu‐Chao Zhang has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Yi‐Long Wu, Jin‐Ji Yang, Qing Zhou, Jian Su, Wen‐Zhao Zhong, Hong‐Hong Yan, Zhi Xie, Hai‐Yan Tu, Xue‐Ning Yang and Zhihong Chen. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.